医药制造业技术创新投入对产出绩效影响的实证研究

发布时间：2018-04-11 05:11

本文选题：医药制造业 + 技术创新投入　；参考：《辽宁大学》2015年硕士论文

【摘要】：从改革开放以来,我国医药制造业发展迅速,对医药制造业技术创新能力对产出绩效的研究已经较为丰富,研究的内容和领域正向不断的深化。但是我国医药制造业存在着子行业发展不均衡、区域发展不均衡的情况,因此本文从子行业、区域两个视角着手,研究医药制造业各个子行业、区域间技术创新投入对产出绩效的不同影响。文章首先阐述以往学者相关的研究综述与基本理论,为后文合理评价和选择衡量指标、方法提供依据,进而对医药制造行业进行界定、描述子行业、区域的发展现状,将医药制造业整体行业划分为化学药品制造、生物制药、中成药,按照区域划分为东部、中部和西部,构建理论模型,对子行业、各区域的投入产出指标进行描述性分析、相关性分析、借助知识生产函数,运用逐步回归的方法对每一子行业和区域进行实证分析,对比得出子行业、区域间的差异,进而得出本文的结论并给出政策建议。通过实证分析本文得出结论,化学制药行业、生物制药行业、中成药行业与东部地区、中部地区、西部地区三个区域技术创新投入与产出情况存在差异,与此同时,影响化学制药行业、生物制药行业、中成药行业、以及东部地区、中部地区、西部地区三个区域医药制造业技术创新投入对产出绩效影响的因素各不相同。经过实证本文得出这样的发现,尽管化学制药行业是医药制造业的典型行业,化学药品制造业消化吸收比重对产出绩效的影响与医药制造业整体消化吸收对产出绩效的作用程度是不同的;经过区域的对比发现,西部地区技术引进对产出绩效的作用、东部地区技术改造对产出绩效的作用弹性与全国医药制造业整体的情况也呈现相反的作用。其次,化学制药行业、生物制药行业、中成药行业、以及东部地区、中部地区、西部地区三个区域,影响其产出绩效的显著因素不尽相同。最后,根据前文的实证部分结论,对比医药制造业中化学制药行业、中成药生产行业、生物药品制造业之间差异以及东部、中部、西部地区之间的差异,从行业、区域的角度为医药制造业行业间、区域间技术创新活动协调发展提供对策。
[Abstract]:Since the reform and opening up, the pharmaceutical manufacturing industry in China has developed rapidly. The research on the technological innovation ability of the pharmaceutical manufacturing industry to the output performance has been relatively rich, and the contents and fields of the research are constantly deepening.However, there is imbalance in the development of sub-industry and regional development in Chinese pharmaceutical manufacturing industry. Therefore, this paper starts with sub-industry and regional perspective, and studies each sub-industry of pharmaceutical manufacturing industry.Different effects of interregional technological innovation input on output performance.The article first describes the previous scholars related to the review and basic theory, for the following reasonable evaluation and selection of measurement indicators, methods to provide the basis, and then to define the pharmaceutical manufacturing industry, describe the development of sub-industry, regional development.The whole industry of pharmaceutical manufacturing is divided into chemical manufacturing, biopharmaceutical, Chinese patent medicine, and divided into the east, middle and west according to the region. The theoretical model is constructed, and the input-output index of the sub-industry and each region is analyzed in a descriptive way.Correlation analysis, with the help of knowledge production function, using the method of stepwise regression for each sub-industry and regional empirical analysis, the comparison of sub-industries, regional differences, and then draw the conclusion of this paper and give policy recommendations.Through the empirical analysis, the paper draws the conclusion that there are differences in the input and output of technological innovation between the chemical pharmaceutical industry, the biopharmaceutical industry, the Chinese patent medicine industry and the eastern, central and western regions, at the same time,The factors that affect the output performance of the three regions are different: chemical pharmaceutical industry, biopharmaceutical industry, Chinese patent medicine industry, as well as the three regions of the eastern region, the central region and the western region.The empirical results of this paper show that although the chemical pharmaceutical industry is a typical industry in the pharmaceutical manufacturing industry,The effect of the proportion of digestion and absorption on the output performance of chemical manufacturing industry is different from that of the pharmaceutical manufacturing industry as a whole, and the regional comparison shows that the technology introduction in the western region plays an important role in the output performance.The elasticity of technological transformation on output performance in eastern China is opposite to that of the whole pharmaceutical manufacturing industry in China.Secondly, chemical pharmaceutical industry, biopharmaceutical industry, Chinese patent medicine industry, as well as the eastern, central and western regions, the significant factors affecting their output performance are different.Finally, according to the empirical conclusions above, the differences among the chemical pharmaceutical industry, the Chinese patent medicine industry, the biological medicine manufacturing industry and the eastern, central and western regions are compared.The regional perspective provides countermeasures for the coordinated development of technological innovation activities in the pharmaceutical manufacturing industry.
【学位授予单位】：辽宁大学
【学位级别】：硕士
【学位授予年份】：2015
【分类号】：F426.72;F273.1

【参考文献】